The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) diving into the opportunity to make effective and targeted ...

* Kroger is working with its merchandising and sourcing teams to diversify the supplier base for some commodities in its ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

Corporate America is scrambling to implement countermeasures as President Donald Trump's latest tariffs on Chinese imports ...

Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some ...

Trump looks forward to such things, but he has made the situation quite complicated for the citizens of his country.

Trade groups are urging the administration to consider the impact on patient care and are pushing for exemptions to the tariffs. Also in the news: Pfizer might move production to the U.S. to combat ...

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...

Jim Cramer remains optimistic about Pfizer’s CEO, Dr. Albert Bourla, despite the company’s struggles with debt and market volatility. Cramer highlighted how Pfizer is leveraging AI in its operations, ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Shares ChatGPT’s Flaws. In this article, we are ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...